Hyderabad to emerge as new biotechnology capital of India: Experts | PharmaBiz.com

Hyderabad, the capital city of Telangana and Andhra Pradesh has the potential to become the biotechnology capital of India in the coming years, opined experts at broacher unveiling ceremony organised by OMICS group in the city. “Though many have projected Bengaluru as the biotech capital of India, in fact it is Hyderabad which has the potential. With numerous research institutes like CCMB, IICT along with private biotech players like GVK Bio, Bharat Biotech, Shanta Biotech, Dr Reddy’s, Mylan etc, the city of Hyderabad is a favourite destination for investments in the bio similar segment,” said Srinubabu, managing director of OMICS International Inc.

According to Dr Kaiser Jamil, Director of Centre for Biotechnology and Bioinformatics, Jawaharlal Nehru Institute of Advanced Studies (JNIAS), there are lots of areas that are left unexplored in the biotechnology segment, with hundreds of biotech drugs coming off patent regime, very soon a large number of national and international companies are expected to focus in this segment and particularly Hyderabad is a favourite destination for new investments in biosimilar, biologics and biowaivers…

Read more PharmaBiz.com